Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026)
Tectonic Therapeutic (TECX) reported Cash from Operations of 18413000.0 for Q1 2026, down 40.74% year-over-year from 31071492.2 in Q1 2025, and down 27.33% quarter-over-quarter from 14461000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Cash from Operations (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Cash from Operations data on file, last reported at 18413000.0 in Q1 2026.
- Cash from Operations for Q1 2026 came in at 18413000.0, down 40.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 65408000.0 (down 4.0% YoY), and the FY2025 annual result was 60078000.0, down 1.69% from the prior year.
- Cash from Operations retreated to 18413000.0 in Q1 2026 per TECX's latest filing, from 14461000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 259000.0 in Q2 2023 and troughed at 29106000.0 in Q2 2022.
- A 5-year average of 16203529.41 and a median of 16415000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 99.11% in 2023, then sank 5066.8% in 2024.
- A 5-year view of Cash from Operations shows it stood at 23673000.0 in 2022, then surged by 50.76% to 11657000.0 in 2023, then plunged by 44.3% to 16821000.0 in 2024, then advanced by 14.03% to 14461000.0 in 2025, then slipped by 27.33% to 18413000.0 in 2026.
- Business Quant data shows TECX's Cash from Operations at 18413000.0 in Q1 2026, 14461000.0 in Q4 2025, and 17815000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -18.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.41 Mn |
| Mar 31, 2026 | -18.41 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Sep 30, 2025 | -17.82 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.08 Mn |
| Mar 31, 2025 | -13.08 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Sep 30, 2024 | -19.60 Mn |
| Sep 30, 2024 | -19.60 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Jun 30, 2024 | -13.38 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -11.66 Mn |
| Dec 31, 2023 | -11.66 Mn |